lobbying_activities: 1840071
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1840071 | 06cb5532-4465-46b7-bade-3634894ba504 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2016 | second_quarter | MED | AACC contacted Senate leaders in support of an amendment included in S.2700, the FDA and NIH Workforce Authorities Modernization Act, which would require the FDA to explain its rationale for choosing to set policy via guidance rather that the ulemaking process. AACC contacted the Centers for Medicare and Medicaid Services and requested that the agency suspend a provision in Memorandum S&C 16-18-CLIA, which grants equivalency to nursing degrees for the purposes of qualifying nurses as high and moderate complexity healthcare personnel. The Association suggested that such changes should have been considered through the rulemaking process. AACC met with congressional staff in support of maintaining CLIA'88 oversight of laboratory developed tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2016-07-12T11:57:56.367000-04:00 |